Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Geonistin vaginal tablets for nonspecific and mixed vulvovaginal infections
2016-000078-39Phase 4Completed
- Sponsor
- PLIVA
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of oxytetracycline + nystatin in Vulvovaginitis and mixed vaginitis, sponsored by PLIVA. Primary endpoint: Clinical cure rate after 6 days of treatment. Started Jul 2016; status: completed.
02
Drugs
oxytetracycline + nystatin
03
Conditions
Vulvovaginitismixed vaginitis
Beyond the preview
Go deeper on 2016-000078-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000078-39.